Teva Pharmaceutical Industries Limited (TLV:TEVA)
10,680
-610 (-5.40%)
At close: Feb 5, 2026
TLV:TEVA Revenue
In the year 2025, Teva Pharmaceutical Industries had annual revenue of $17.26B USD with 4.32% growth. Teva Pharmaceutical Industries had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.
Revenue
$17.26B
Revenue Growth
+4.32%
P/S Ratio
2.26
Revenue / Employee
$466.43K
Employees
37,000
Market Cap
124.61B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.26B | 714.00M | 4.32% |
| Dec 31, 2024 | 16.54B | 698.00M | 4.40% |
| Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
| Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
| Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
| Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
| Dec 31, 2019 | 16.89B | -1.38B | -7.57% |
| Dec 31, 2018 | 18.27B | -3.58B | -16.39% |
| Dec 31, 2017 | 21.85B | -50.00M | -0.23% |
| Dec 31, 2016 | 21.90B | 2.25B | 11.45% |
| Dec 31, 2015 | 19.65B | -620.00M | -3.06% |
| Dec 31, 2014 | 20.27B | -42.00M | -0.21% |
| Dec 31, 2013 | 20.31B | -3.00M | -0.01% |
| Dec 31, 2012 | 20.32B | 2.01B | 10.95% |
| Dec 31, 2011 | 18.31B | 2.19B | 13.59% |
| Dec 31, 2010 | 16.12B | 2.22B | 15.99% |
| Dec 31, 2009 | 13.90B | 2.81B | 25.39% |
| Dec 31, 2008 | 11.09B | 1.68B | 17.83% |
| Dec 31, 2007 | 9.41B | 1.00B | 11.89% |
| Dec 31, 2006 | 8.41B | 3.16B | 60.15% |
| Dec 31, 2005 | 5.25B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.87B |
| Novolog (Pharm-Up 1966) | 1.97B |
| Ilex Medical | 917.10M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| Golden House | 46.05M |
Teva Pharmaceutical Industries News
- 10 hours ago - Teva (TEVA) Q4 2024 Earnings Call Transcript - The Motley Fool
- 10 hours ago - Teva (TEVA) Q3 2024 Earnings Call Transcript - The Motley Fool
- 10 hours ago - A Look Into Teva Pharmaceutical Indus Inc's Price Over Earnings - Benzinga
- 13 hours ago - Teva Pharmaceutical Industries Ltd (TEVA) Stock Price Down 0% on Feb 5 - GuruFocus
- 2 days ago - Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight - GuruFocus
- 2 days ago - Teva Pharmaceutical Industries Ltd (TEVA) Shares Up 3.39% on Feb 3 - GuruFocus
- 2 days ago - Notable ETF Inflow Detected - IDEV, SPOT, SE, TEVA - Nasdaq
- 4 days ago - Q4 2025 Teva Pharmaceutical Industries Ltd Earnings Call Transcript - GuruFocus